Advertisement

Topics

ENBREL Company Profile

13:56 EST 17th December 2018 | BioPortfolio

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis, have too much TNF in their bodies. ENBREL can reduce the amount of TNF in the body to normal levels, helping to treat your disease. But, in doing so, ENBREL can also lower the ability of your immune system to fight infections.All medicines have side effects, including ENBREL. Possible side effects of ENBREL include:Serious infections
Many occurred in people prone to infection, such as those with advanced or poorly controlled diabetes Some serious infections have been fatal

Location

Thousand Oaks
California
91320
United States of America

Contact

Email: webcoordinator@amgen.com


News Articles [32 Associated News Articles listed on BioPortfolio]

Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar

Enbrel is a TNF-inhibitor 1indicated to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Enbrel had global brand ...

Medical News Today: Differences between Enbrel and Humira

Enbrel and Humira are medications that doctors prescribe to treat rheumatoid arthritis and other conditions. Both help lower inflammation in the joints and are similar, regarding their available forms...

Clover Biopharma Starts China Phase I Trial of Enbrel Biosimilar

Clover Biopharma (Chengdu) has dosed the first patient in a China Phase I trial of its Enbrel® (etanercept) biosimilar. Enbrel, an Amgen treatment for rheumatoid arthritis and other autoimmune dis...

Mylan to market Lupin's Enbrel biosimilar outside US

Mylan has joined with India’s Lupin to market a biosimilar of Amgen/Pfizer’s inflammatory diseases blockbuster Enbrel (etanercept) in ex-US markets. Approved in a range of diseases including rheu...

First Head-to-Head Trial of a TNF Inhibitor Versus Methotrexate Monotherapy in Psoriatic Arthritis Shows ENBREL® (Etanercept) Monotherapy and Combination Therapy Both Superior to Methotrexate

Results From Head-To-Head Phase 3 SEAM-PsA Study Assessing ENBREL and Methotrexate Regimens in Patients With Psoriatic Arthritis Presented at 2018 ACR/ARHP Annual Meeting Additional Phase 3b Results ...

New Warning for Arthritis Drug Enbrel

FDA is advising physicians about new safety concerns regarding the use of etanercept (Enbrel), a product recently approved to treat moderate to severe rheumatoid arthritis (RA)...

Amgen extends patent protection on Enbrel

About 75% of the 57 patent applications Amgen has filed on Enbrel came after the drug was approved by the FDA in 1998.  -More- 

Study Finds Enbrel Monotherapy and Combination Therapy Both Superior to Methotrexate in Patients with Psoriatic Arthritis

THOUSAND OAKS, Calif., Oct. 24, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that positive results from the Phase 3 SEAM-PsA study comparing the efficacy of Enbrel® (etanercept)...

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Enbrel [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Enbrel safely and effectively. See full prescribing information for Enbrel.Enbrel (etanercept)Solution for Subcutaneous UseInitial U.S...

Enbrel [Immunex Corporation]

These highlights do not include all the information needed to use Enbrel safely and effectively. See full prescribing information for Enbrel. Enbrel (etanercept)Solution for Subcutaneous UseInitial U....

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Assessment of the higher order structure of Humira®, Remicade®, Avastin®, Rituxan®, Herceptin®, and Enbrel® by 2D-NMR fingerprinting.

The advent of monoclonal antibody biosimilar products has stimulated the development of analytical methods that can better characterize an important quality attribute, namely the higher order structur...

Clinical Trials [70 Associated Clinical Trials listed on BioPortfolio]

Canadian Assessment of Patient Outcomes and Effectiveness of Enbrel in Psoriasis

The purpose of this study is to evaluate the use of Enbrel® (etanercept) in the treatment of psoriasis in patients for a period of up to 1 year.

Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

To investigate the changes in MRI-derived markers of joint inflammation and destruction and in biochemical markers of connective tissue metabolism and angiogenesis in rheumatoid arthritis ...

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

The special use-results surveillance is conducted in patients who have never been treated with Enbrel and in whom its long-term therapy may be instituted in the actual setting of use after...

Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

The purpose of this study is to investigate the incidence of adverse events for patients with rheumatoid arthritis treated with Enbrel under usual care settings. In addition, differences ...

Prospective Evaluation of the Radiographic Efficacy of Enbrel

It is known from the COMET-trial that patients who start Enbrel treatment early have a great chance of reaching clinical remission and radiographic nonprogression. It is still unclear, how...

Companies [3 Associated Companies listed on BioPortfolio]

ENBREL

ENBREL is a type of protein called a tumor necrosis factor (TNF) blocker that blocks the action of a substance your body's immune system makes called TNF. People with an immune disease, such as rheuma...

Enbrel® (etanercept)

Enbrel® (etanercept) is a TNF inhibitor approved for the following indications: moderately to severely active rheumatoid arthritis, polyarticular-course juvenile rheumatoid arthritis, psoriatic arthr...

VLST Corp

VLST Corporation discovers and develops novel therapeutics for the treatment of inflammatory and autoimmune diseases. Disease areas in which the company’s technology may have utility include multip...

More Information about "ENBREL" on BioPortfolio

We have published hundreds of ENBREL news stories on BioPortfolio along with dozens of ENBREL Clinical Trials and PubMed Articles about ENBREL for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ENBREL Companies in our database. You can also find out about relevant ENBREL Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...


Corporate Database Quicklinks



Searches Linking to this Company Record